Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 4
2005 4
2006 1
2007 2
2008 1
2009 1
2010 3
2011 2
2012 4
2013 9
2014 4
2015 10
2016 3
2017 7
2018 9
2019 7
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
Gene therapy: evidence, value and affordability in the US health care system.
Hampson G, Towse A, Pearson SD, Dreitlein WB, Henshall C. Hampson G, et al. Among authors: towse a. J Comp Eff Res. 2018 Jan;7(1):15-28. doi: 10.2217/cer-2017-0068. Epub 2017 Nov 16. J Comp Eff Res. 2018. PMID: 29144165 Free article. Review.
Specific Value Assessment Considerations.
Kamal-Bahl S, Towse A, Spurgin L, Danzon PM. Kamal-Bahl S, et al. Among authors: towse a. Value Health. 2019 Jun;22(6S):S24-S28. doi: 10.1016/j.jval.2019.04.1920. Value Health. 2019. PMID: 31200803 Free article. No abstract available.
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.
Garrison LP Jr, Towse A, Briggs A, de Pouvourville G, Grueger J, Mohr PE, Severens JL, Siviero P, Sleeper M. Garrison LP Jr, et al. Among authors: towse a. Value Health. 2013 Jul-Aug;16(5):703-19. doi: 10.1016/j.jval.2013.04.011. Epub 2013 Jul 19. Value Health. 2013. PMID: 23947963 Free article.
Affordability of New Technologies: The Next Frontier.
Towse A, Mauskopf JA. Towse A, et al. Value Health. 2018 Mar;21(3):249-251. doi: 10.1016/j.jval.2018.01.011. Epub 2018 Feb 19. Value Health. 2018. PMID: 29566829 Free article. No abstract available.
Is rate of return pricing a useful approach when value-based pricing is not appropriate?
Drummond M, Towse A. Drummond M, et al. Among authors: towse a. Eur J Health Econ. 2019 Sep;20(7):945-948. doi: 10.1007/s10198-019-01032-7. Eur J Health Econ. 2019. PMID: 30771033 No abstract available.
Establishing a reasonable price for an orphan drug.
Berdud M, Drummond M, Towse A. Berdud M, et al. Among authors: towse a. Cost Eff Resour Alloc. 2020 Sep 4;18:31. doi: 10.1186/s12962-020-00223-x. eCollection 2020. Cost Eff Resour Alloc. 2020. PMID: 32908456 Free PMC article.
Economic evaluation of meningococcal vaccines: considerations for the future.
Christensen H, Al-Janabi H, Levy P, Postma MJ, Bloom DE, Landa P, Damm O, Salisbury DM, Diez-Domingo J, Towse AK, Lorgelly PK, Shah KK, Hernandez-Villafuerte K, Smith V, Glennie L, Wright C, York L, Farkouh R. Christensen H, et al. Among authors: towse ak. Eur J Health Econ. 2020 Mar;21(2):297-309. doi: 10.1007/s10198-019-01129-z. Epub 2019 Nov 21. Eur J Health Econ. 2020. PMID: 31754924 Free PMC article.
Paying for Cures: Perspectives on Solutions to the "Affordability Issue".
Schaffer SK, Messner D, Mestre-Ferrandiz J, Tambor E, Towse A. Schaffer SK, et al. Among authors: towse a. Value Health. 2018 Mar;21(3):276-279. doi: 10.1016/j.jval.2017.12.013. Value Health. 2018. PMID: 29566833 Free article. Review.
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment-Rationale and Empirical Support.
Garrison LP Jr, Zamora B, Li M, Towse A. Garrison LP Jr, et al. Among authors: towse a. J Manag Care Spec Pharm. 2020 Apr;26(4):400-406. doi: 10.18553/jmcp.2020.26.4.400. J Manag Care Spec Pharm. 2020. PMID: 32223599
Reforming the cancer drug fund.
Buxton M, Longworth L, Raftery J, Sculpher M, Towse A. Buxton M, et al. Among authors: towse a. BMJ. 2014 Nov 28;349:g7276. doi: 10.1136/bmj.g7276. BMJ. 2014. PMID: 25432928 No abstract available.
74 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page